$WORX
SCWorx Corp.

2024 Q3 Form 10-Q Financial Statement

#000121390024098398 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $759.7K
YoY Change -16.15%
Cost Of Revenue $627.1K
YoY Change -5.95%
Gross Profit $132.6K
YoY Change -44.6%
Gross Profit Margin 17.45%
Selling, General & Admin $526.1K
YoY Change -52.18%
% of Gross Profit 396.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $526.1K
YoY Change -51.74%
Operating Profit -$393.5K
YoY Change -54.14%
Interest Expense -$31.47K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$31.47K
YoY Change 11300.36%
Pretax Income -$425.0K
YoY Change -50.49%
Income Tax
% Of Pretax Income
Net Earnings -$425.0K
YoY Change -50.49%
Net Earnings / Revenue -55.94%
Basic Earnings Per Share -$0.27
Diluted Earnings Per Share -$0.27
COMMON SHARES
Basic Shares Outstanding 1.599M shares
Diluted Shares Outstanding 1.560M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $87.67K
YoY Change 25.24%
Cash & Equivalents $87.67K
Short-Term Investments
Other Short-Term Assets $45.38K
YoY Change -24.37%
Inventory
Prepaid Expenses
Receivables $546.9K
Other Receivables $0.00
Total Short-Term Assets $680.0K
YoY Change 51.05%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $5.842M
YoY Change -30.17%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.842M
YoY Change -30.17%
TOTAL ASSETS
Total Short-Term Assets $680.0K
Total Long-Term Assets $5.842M
Total Assets $6.522M
YoY Change -26.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.762M
YoY Change 7404.41%
Accrued Expenses
YoY Change
Deferred Revenue $159.3K
YoY Change
Short-Term Debt $41.95K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.030M
YoY Change -20.59%
LONG-TERM LIABILITIES
Long-Term Debt $7.110K
YoY Change -92.89%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.112K
YoY Change -92.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.030M
Total Long-Term Liabilities $7.112K
Total Liabilities $2.038M
YoY Change -23.31%
SHAREHOLDERS EQUITY
Retained Earnings -$30.78M
YoY Change 12.87%
Common Stock $1.599K
YoY Change -91.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.485M
YoY Change
Total Liabilities & Shareholders Equity $6.522M
YoY Change -26.02%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$425.0K
YoY Change -50.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$362.6K
YoY Change -2.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 433.0K
YoY Change 39.68%
NET CHANGE
Cash From Operating Activities -362.6K
Cash From Investing Activities
Cash From Financing Activities 433.0K
Net Change In Cash 70.40K
YoY Change -217.33%
FREE CASH FLOW
Cash From Operating Activities -$362.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37899
dei Entity Registrant Name
EntityRegistrantName
SCWORX CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5412331
dei Entity Address Address Line1
EntityAddressAddressLine1
100 S Ashley Dr
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33602
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
739-7825
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
WORX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1626967 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87666 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91436 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
546916 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
304813 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45383 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39533 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
679965 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
435782 usd
CY2024Q3 us-gaap Goodwill
Goodwill
5842433 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5842433 usd
CY2024Q3 us-gaap Assets
Assets
6522398 usd
CY2023Q4 us-gaap Assets
Assets
6278215 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1611668 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1738364 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67622 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67622 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
159333 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
378583 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
41949 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2030410 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2334407 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
90359 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
7112 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7112 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
90359 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2037522 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2424766 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
40 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
40 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1599367 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1599367 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1232333 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1232333 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1599 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1232 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35264013 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33692018 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30780776 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29839841 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4484876 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3853449 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6522398 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6278215 usd
CY2024Q3 us-gaap Revenues
Revenues
759724 usd
CY2023Q3 us-gaap Revenues
Revenues
906099 usd
us-gaap Revenues
Revenues
2313850 usd
us-gaap Revenues
Revenues
2894647 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
627148 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
666808 usd
us-gaap Cost Of Revenue
CostOfRevenue
1726314 usd
us-gaap Cost Of Revenue
CostOfRevenue
1972300 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
132576 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
239291 usd
us-gaap Gross Profit
GrossProfit
587536 usd
us-gaap Gross Profit
GrossProfit
922347 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
253603 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
305879 usd
us-gaap Legal Fees
LegalFees
737157 usd
us-gaap Legal Fees
LegalFees
706350 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
75480 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
78046 usd
us-gaap Salaries And Wages
SalariesAndWages
199475 usd
us-gaap Salaries And Wages
SalariesAndWages
247581 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
40547 usd
us-gaap Share Based Compensation
ShareBasedCompensation
336293 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
196991 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
672801 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
530005 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1037985 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
526074 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1097273 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1466637 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2328209 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-393498 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-857982 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-879101 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1405862 usd
CY2024Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
31465 usd
CY2023Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
276 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
61834 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
6208 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31465 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-276 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61834 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6208 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424963 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-858258 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-940935 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1412070 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-424963 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-858258 usd
us-gaap Net Income Loss
NetIncomeLoss
-940935 usd
us-gaap Net Income Loss
NetIncomeLoss
-1412070 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1560213 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1560213 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1126541 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1126541 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1367162 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1367162 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
972831 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
972831 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3608721 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56171 usd
CY2024Q3 worx Stock Issued During Period Value Shares Issued For Legal Settlement
StockIssuedDuringPeriodValueSharesIssuedForLegalSettlement
271747 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
973200 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-424963 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4484876 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3853449 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
239815 usd
worx Stock Issued During Period Value Shares Issued For Legal Settlement
StockIssuedDuringPeriodValueSharesIssuedForLegalSettlement
359347 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
973200 usd
us-gaap Net Income Loss
NetIncomeLoss
-940935 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4484876 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6594308 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71978 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
311219 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40547 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-858258 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
6159794 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6776520 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
116145 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
342906 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
336293 usd
us-gaap Net Income Loss
NetIncomeLoss
-1412070 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
6159794 usd
us-gaap Net Income Loss
NetIncomeLoss
-940935 usd
us-gaap Net Income Loss
NetIncomeLoss
-1412070 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37112 usd
us-gaap Share Based Compensation
ShareBasedCompensation
336293 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
239815 usd
worx Issuance Of Stock Issuedf For Legal Settlements
IssuanceOfStockIssuedfForLegalSettlements
74053 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25500 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
64000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
267603 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50650 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5850 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10147 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
107298 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
538998 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-219250 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-188000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-949860 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-701282 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
572906 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
994500 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
48410 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
47847 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
24283 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
128479 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
183558 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-128479 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-160085 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
946090 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
524249 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3770 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-177033 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91436 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249462 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87666 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72429 usd
us-gaap Interest Paid Net
InterestPaidNet
30499 usd
us-gaap Interest Paid Net
InterestPaidNet
5932 usd
worx Shares Issued For Vested Restricted Stock Units
SharesIssuedForVestedRestrictedStockUnits
2 usd
worx Shares Issued For Vested Restricted Stock Units
SharesIssuedForVestedRestrictedStockUnits
16 usd
worx Shares Issued For Settlement Of Class Action
SharesIssuedForSettlementOfClassAction
600000 usd
us-gaap Stock Issued1
StockIssued1
15 usd
worx Shares Issued For Accrued Legal Settlement
SharesIssuedForAccruedLegalSettlement
285294 usd
worx Beneficial Conversion Feature On Convertible Loans
BeneficialConversionFeatureOnConvertibleLoans
973200 usd
worx Acquired Technology Predecessor Cost
AcquiredTechnologyPredecessorCost
0 usd
CY2018Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
1250000 usd
CY2018Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3125 shares
CY2023Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 15
CY2023Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The effect of the reverse stock split was to combine every 15 shares of outstanding common stock into one share of common stock.
us-gaap Net Income Loss
NetIncomeLoss
-940935 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3981144 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30780776 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain balances in previously issued unaudited condensed consolidated financial statements have been reclassified to be consistent with the current period presentation. The reclassification had no impact on total financial position, net loss, or stockholders’ equity.</p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit and Other Risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing internal credit evaluations of its customers’ financial condition, obtains deposits and limits the amount of credit extended when deemed necessary but generally requires no collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant customers are those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total net accounts receivable are as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Revenue For the</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Accounts</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">nine months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Receivable</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Customers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">14</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left">%</td></tr> </table>
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
159333 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
378583 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
159333 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
378583 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
365083 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
513833 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the unaudited consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to the allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Actual results could differ materially from those estimates.</p>
CY2024Q3 us-gaap Loans Payable
LoansPayable
41949 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
90359 usd
CY2024Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
300000 usd
CY2024Q3 worx Aggregate Convertible Note
AggregateConvertibleNote
1155000 usd
CY2024Q3 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.10 pure
CY2024Q3 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
1.43
CY2024Q3 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
4887118 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
973200 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
7112 usd
us-gaap Payments For Rent
PaymentsForRent
250 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1206 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
392 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3339 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1262 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
1206 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
392 usd
us-gaap Lease Cost
LeaseCost
3339 usd
us-gaap Lease Cost
LeaseCost
1262 usd
CY2023Q4 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
461856 usd
CY2023 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
502000 usd
CY2024Q3 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
502000 usd
worx Settlement Agreement Value
SettlementAgreementValue
283906 usd
CY2022Q4 worx Loss Contingency Payments Of Plaintiffs
LossContingencyPaymentsOfPlaintiffs
20000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2023Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 15
CY2023Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The effect of the reverse stock split was to combine every 15 shares of outstanding common stock into one share of common stock.
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
239815 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37500 usd
CY2024Q2 worx Shares Issued For Accrued Legal Settlement
SharesIssuedForAccruedLegalSettlement
67200 usd
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.79
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38052 usd
CY2024Q3 worx Shares Issued For Accrued Legal Settlement
SharesIssuedForAccruedLegalSettlement
53653 usd
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.41
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
159776 usd
CY2024Q3 worx Shares Issued For Accrued Legal Settlement
SharesIssuedForAccruedLegalSettlement
218094 usd
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.36
CY2024Q3 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
4887118 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
973200 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40547 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
336293 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5021826 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
217937 shares
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67622 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67622 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
39700000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
38800000 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
19100000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
18200000 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12290000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12126000 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
164000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0165 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2265 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
worx Stock Issued During Period Value Shares Issued For Settlement Of Class Action
StockIssuedDuringPeriodValueSharesIssuedForSettlementOfClassAction
usd
worx Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
worx Issuance Of Stock Issuedf For Legal Settlements
IssuanceOfStockIssuedfForLegalSettlements
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
worx Shares Issued For Settlement Of Class Action
SharesIssuedForSettlementOfClassAction
usd
us-gaap Stock Issued1
StockIssued1
usd
worx Shares Issued For Accrued Legal Settlement
SharesIssuedForAccruedLegalSettlement
usd
worx Beneficial Conversion Feature On Convertible Loans
BeneficialConversionFeatureOnConvertibleLoans
usd
us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
usd
CY2023 us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001674227

Files In Submission

Name View Source Status
0001213900-24-098398-index-headers.html Edgar Link pending
0001213900-24-098398-index.html Edgar Link pending
0001213900-24-098398.txt Edgar Link pending
0001213900-24-098398-xbrl.zip Edgar Link pending
ea0218705-10q_scworx.htm Edgar Link pending
ea021870501ex31-1_scworx.htm Edgar Link pending
ea021870501ex31-2_scworx.htm Edgar Link pending
ea021870501ex32-1_scworx.htm Edgar Link pending
ea021870501ex32-2_scworx.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
ea0218705-10q_scworx_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
worx-20240930.xsd Edgar Link pending
worx-20240930_def.xml Edgar Link unprocessable
worx-20240930_lab.xml Edgar Link unprocessable
worx-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
worx-20240930_cal.xml Edgar Link unprocessable